The agency greenlit the drug, which will be marketed as Beqvez, for adults with moderate to severe hemophilia B.
Then her medical team offered her a potential lifeline: a first-of-its-kind experimental drug called sotatercept that corrals a growth factor that is overproduced by people with PAH, potentially ...
It represents the first systemic therapy for pediatric low-grade gliomas harboring BRAF rearrangements, or fusions, according ...
Carvykti is the first and only BCMA-targeted treatment approved by the ... multiple-myeloma-302090580.html 4. Caffrey M. FDA approves cilta-cel to treat R/R multiple myeloma.
The approval for Pivya was given to Utility Therapeutics, a U.S. company that acquired the rights to the drug. It is expected to become available in 2025. In clinical trials, Pivya outperformed ...
So, it's welcome news that the U.S. Food and Drug Administration on Wednesday approved Pivya (pivmecillinam) to fight bacterial UTIs. "UTIs are a very common condition impacting women and one of ...
The Sepsis ImmunoScore uses 22 diagnostic and predictive parameters to calculate the risk of a patient developing sepsis within 24 hours, a criteria combination that has “never previously been ...
By Andrew Jacobs The Food and Drug Administration on Wednesday approved the sale of an antibiotic for the treatment of urinary tract infections in women, giving U.S. health providers a powerful ...
opens new tab drug to treat manic and mixed episodes associated with a type of bipolar disorder, the company said on Tuesday, marking the second approval for the treatment. Shares of the ...
Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The FDA expanded the labels of two CAR T-cell products for ...
Now, the Food and Drug Administration has greenlighted such a test developed by Reddy’s company, Chicago-based Prenosis, to predict the risk of sepsis — a complex condition that contributes to ...
Medtronic said Friday that the U.S. Food and Drug Administration has approved a new spinal-cord implant that relieves chronic pain, a bid to expand into a patient population that relies heavily on ...